Join
Live feed
·
INSIDERFilingvia Quantisnow
Verona Pharma plc logo

Director Brady James Aloysius returned 95,176 units of Ordinary Shares to the company and converted options into 72,000 units of Ordinary Shares, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VRNA· Verona Pharma plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRNA (Verona Pharma plc) and more on Quantisnow.